This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why You Shouldn't Bet Against AMERISAFE (AMSF) Stock
by Zacks Equity Research
AMERISAFE, Inc. (AMSF) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Is Amerisafe (AMSF) a Great Stock for Value Investors?
by Zacks Equity Research
Is Amerisafe (AMSF) a great pick from the value investor's perspective right now? Read on to know more.
Why the Earnings Streak Will Continue for Amerisafe (AMSF)
by Zacks Equity Research
Amerisafe (AMSF) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
Amerisafe Maintains Niche Position in High Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) niche presence in workers' compensation insurance market operating high-hazard industries makes it a specialty insurer.
Unum (UNM) Rides High on Growth Prospects: Time to Buy?
by Zacks Equity Research
Unum (UNM) appears an attractive pick on the back of growth projections and upward estimate revisions.
The Zacks Analyst Blog Highlights: Primerica, Amerisafe, Employers Holdings and Unum Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Primerica, Amerisafe, Employers Holdings and Unum Group
4 Solid Insurance Stocks to Hit High Spots in Q4 Bull Market
by Zacks Equity Research
We close in on four insurance stocks likely to perform well in Q4, riding high on core strengths.
Amerisafe (AMSF) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Earnings growth and lower expenses are reflected in Amerisafe's (AMSF) Q3 performance.
Will Revenue Growth Aid Marsh & McLennan (MMC) Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter earnings are likely to benefit from strong contribution by both its operating segments.
Key Predictions for Q3 Earnings Reports of AFL, UNM, AMSF
by Zacks Equity Research
The third quarter witnessed a slew of catastrophes, which will weigh on underwriting profitability as well as the bottom line of insurers.
Will Visa (V) Q4 Earnings Buoy Up on Better Payment Volumes?
by Zacks Equity Research
Visa (V) fourth-quarter earnings likely to benefit from increased payments volumes, lower client incentives and accelerated share buyback among other factors.
Will Strong U.S. Business Aid Aflac's (AFL) Q3 Earnings?
by Zacks Equity Research
Aflac's (AFL) third-quarter earnings are likely to benefit from strong contribution by its U.S. segment, partly offset by weakness in its Japan business.
Is a Beat in the Cards for Progressive (PGR) in Q3 Earnings?
by Zacks Equity Research
An improving top line might help Progressive (PGR) exceed estimates this earnings season.
Aflac Well Poised on U.S. Unit, Currency Volatility Hurts
by Zacks Equity Research
Aflac's (AFL) strong U.S. business impresses but its large exposure to Japan exposes it to low interest woes and foreign exchange volatility.
Allstate Hits 52-Week High on Strong Results, Expansion Plan
by Zacks Equity Research
Allstate (ALL) hits 52-week high on second-quarter results, increase in share buyback authorization and expansion plans.
MetLife Suffers From Declining Revenues, Spinoff Charges
by Zacks Equity Research
MetLife's (MET) declining revenues, low premiums, fees and other revenues continue to bother.
Amerisafe (AMSF) Q2 Earnings Beat Estimates, Decrease Y/Y
by Zacks Equity Research
Declining revenues hurt Amerisafe's (AMSF) profitability in Q2 earnings.
Aflac (AFL) Q2 Earnings Beat Estimates, Guidance Intact
by Zacks Equity Research
Aflac's (AFL) better-than-expected results were driven by favorable performance in its U.S. segment, partly offset by foreign currency movement.
AMERISAFE (AMSF) Down 10.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
AMERISAFE (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What Makes Amerisafe (AMSF) a Strong Sell?
by Zacks Equity Research
Amerisafe, Inc. (AMSF) has witnessed a significant price decline in the past four weeks and it has seen negative earnings estimate revisions for the current quarter and the current year.
New Strong Sell Stocks for May 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Aflac (AFL) Q1 Earnings Beat, Revenues Miss, Guidance Intact
by Zacks Equity Research
Aflac Inc.'s (AFL) first-quarter 2017 earnings of $1.67 per share surpassed the Zacks Consensus Estimate by 3.09% but decreased 3.5% year over year.
Amerisafe (AMSF) Q1 Earnings Lag Estimates on Lower Premiums
by Zacks Equity Research
Amerisafe's (AMSF) earnings were affected by lower revenues stemming from a decline in premiums as the company slashed prices in order to counter a soft and competitive market.
Why Is AMERISAFE (AMSF) Down 6% Since the Last Earnings Report?
by Zacks Equity Research
AMERISAFE (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amerisafe (AMSF) Q4 Earnings Meet, Revenues Miss Estimates
by Zacks Equity Research
Amerisafe Inc. (AMSF) bottom line deteriorated 13.3% year over year due to lower revenues, which in turn, were hurt by a decline in premiums written.